THOMPSON SIEGEL & WALMSLEY LLC

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1008322 RICHMOND, VA

Back to XERS Full portfolio

Position in XERS

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$500,656

-$291,283 QoQ

Shares Held

86,320

-14.4% QoQ

Ownership

0.050%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

THOMPSON SIEGEL & WALMSLEY LLC holds $124,816,124 across 6 Drug Manufacturers - Specialty & Generic names. XERS ranks #6 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	3,838,892	$51,863,430
2	PRGO	PERRIGO Co plc	3,753,900	$40,316,886
3	LNTH	Lantheus Holdings, Inc.	176,967	$13,422,946
4	ETON	Eton Pharmaceuticals, Inc.	406,089	$10,022,276
5	ANIP	Ani Pharmaceuticals Inc	113,003	$8,689,930
6	XERS	Xeris Biopharma Holdings, Inc. This page	86,320	$500,656

All Filings in XERS

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$500,656	86,320	-14.4%	Shares	Defined	2026-05-11
2025-12-31	$791,939	100,884	0.0%	Shares	Defined	2026-02-10
2025-09-30	$821,195	100,884	-62.1%	Shares	Defined	2025-11-12
2025-06-30	$1,244,027	266,387	+54.2%	Shares	Defined	2025-08-06
2025-03-31	$948,584	172,784	+13.1%	Shares	Defined	2025-05-09
2024-12-31	$517,937	152,784	-11.6%	Shares	Defined	2025-02-10
2024-09-30	$492,434	172,784	0.0%	Shares	Defined	2024-11-12
2024-06-30	$388,764	172,784	-9.1%	Shares	Defined	2024-08-08
2024-03-31	$419,900	190,000	—	Shares	Defined	2024-05-09
No filing history on record for this holder in this stock.